Figure 2From: Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cellsSynergistic drug combinations in JC and JC-pl. A: Comparison of expected and observed relative viability of JC after combination treatment with EPD and paclitaxel. B: Lower doses of EPD and cisplatin were found to be antagonistic for JC-pl, whereas the higher doses showed synergistic effects.Back to article page